{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:09:41Z","timestamp":1754194181485},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12094-010-0568-7","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T15:52:28Z","timestamp":1285170748000},"page":"629-633","source":"Crossref","is-referenced-by-count":10,"title":["Fifty-one Kaposi sarcoma patients"],"prefix":"10.1007","volume":"12","author":[{"given":"Mutlu","family":"Dogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfi","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyyaz","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye","family":"Yildirim Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Senol Coskun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulku","family":"Yalcintas Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guze","family":"Ozal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gungor","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Demirkazik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazil","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurullah","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikri","family":"Icli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,23]]},"reference":[{"key":"568_CR1","first-page":"693","volume":"36","author":"H.W. Wang","year":"2004","unstructured":"Wang HW, Trotter MW, Lagos D et al (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36:693","journal-title":"Nat Genet"},{"key":"568_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","volume":"2","author":"U.R. Hengge","year":"2002","unstructured":"Hengge UR, Ruzicka T, Tyring SK et al (2002) Update on Kaposi sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2:281\u2013292","journal-title":"Lancet Infect Dis"},{"key":"568_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/DAD.0b013e3181a58234","volume":"31","author":"M. Dubina","year":"2009","unstructured":"Dubina M, Goldenberg G (2009) Viral-associated nonmelanoma skin cancers: a review. Am J Dermatopathol 31:561\u2013573","journal-title":"Am J Dermatopathol"},{"key":"568_CR4","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y. Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi sarcoma. Science 266:1865\u20131869","journal-title":"Science"},{"key":"568_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01541091","volume":"15","author":"L. Strichman-Almashanau","year":"1995","unstructured":"Strichman-Almashanau L, Weltfriend S, Gideoni O (1995) No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients. J Clin Immunol 15: 205\u2013209","journal-title":"J Clin Immunol"},{"key":"568_CR6","first-page":"51","volume":"3","author":"D.L. Mann","year":"1990","unstructured":"Mann DL, Murray C, O\u2019Donnell M (1990) HLA antigen frequencies in HIV-1-related Kaposi sarcoma. J Acquir Immune Defic Synd 3:51\u201355","journal-title":"J Acquir Immune Defic Synd"},{"key":"568_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cellbi.2007.08.021","volume":"32","author":"M.R. Hussein","year":"2008","unstructured":"Hussein MR (2008) Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi sarcoma. Cell Biol Int 32:157\u2013162","journal-title":"Cell Biol Int"},{"key":"568_CR8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/jmv.21188","volume":"80","author":"M.C. Nascimento","year":"2008","unstructured":"Nascimento MC, de Souza VA, Sumita LM et al (2008) Prevalence of, and Risk Factors for Kaposi Sarcoma-Associated Herpesvirus Infection Among Blood Donors in Brazil: A Multi-Center Serosurvey. J Med Virology 80:1202\u20131210.","journal-title":"J Med Virology"},{"key":"568_CR9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archinternmed.2009.104","volume":"169","author":"N. Crum-Cianflone","year":"2009","unstructured":"Crum-Cianflone N, Hullsiek KH, Satter E et al (2009) Cutaneous malignancies among HIV-infected persons. Arch Intern Med 169:1130\u20131138","journal-title":"Arch Intern Med"},{"key":"568_CR10","doi-asserted-by":"crossref","unstructured":"Wen KW, Damania B (2009) Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett doi: 10.1016\/j.canlet.2009.07.004","DOI":"10.1016\/j.canlet.2009.07.004"},{"key":"568_CR11","first-page":"121","volume":"3","author":"P. Ahmadpoor","year":"2009","unstructured":"Ahmadpoor P (2009) Human herpes virus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. Iran J Kidney Dis 3:121\u2013126","journal-title":"Iran J Kidney Dis"},{"key":"568_CR12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.transproceed.2009.03.009","volume":"41","author":"P. Piselli","year":"2009","unstructured":"Piselli P, Busnach G, Citterio F et al, for the Immunosuppression and Cancer Study Group (2009) Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970\u20132006. Transplant Proc 41:1227\u20131230","journal-title":"Transplant Proc"},{"key":"568_CR13","first-page":"1121","volume":"10","author":"L.J. Conley","year":"1996","unstructured":"Conley LJ, Bush TJ, Buchbinder SP (1996) The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10: 1121\u20131126","journal-title":"AIDS"},{"key":"568_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jso.20090","volume":"87","author":"R.A. Schwartz","year":"2004","unstructured":"Schwartz RA (2004) Kaposi sarcoma: an update. J Surg Oncol 87:146\u2013151","journal-title":"J Surg Oncol"},{"key":"568_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-200868001-00003","volume":"68","author":"A. Kapoor","year":"2008","unstructured":"Kapoor A (2008) Malignancy in kidney transplant recipients. Drugs 68:11\u201319","journal-title":"Drugs"},{"key":"568_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","volume":"31","author":"S.E. Krown","year":"2004","unstructured":"Krown SE, Northfelt DW, Osoba D, Stewart JS (2004) Use of liposomal anthracyclines in Kaposi sarcoma. Semin Oncol 31:36\u201352","journal-title":"Semin Oncol"},{"key":"568_CR17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0959-8049(01)00053-3","volume":"37","author":"U.R. Hengge","year":"2001","unstructured":"Hengge UR, Esser S, Rudel HP, Goos M (2001) Long-term chemotherapy of HIV-associated Kaposi sarcoma with liposomal doxorubicin. Eur J Cancer 37:878\u2013883","journal-title":"Eur J Cancer"},{"key":"568_CR18","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1365-2133.2008.08517.x","volume":"158","author":"L. Brambilla","year":"2008","unstructured":"Brambilla L, Romanelli A, Bellinvia M (2008) Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. Br J Dermatol 158:1339\u20131344","journal-title":"Br J Dermatol"},{"key":"568_CR19","unstructured":"Ramirez-Rodriguez JM, Morgan-Villela G, Robles-Toscano JA, Echeagaray E (1996) Therapeutic response of the epidemic Kaposi Sarcoma. Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 212 (abstract I142)"},{"key":"568_CR20","first-page":"675","volume":"29","author":"N. Silvestris","year":"2009","unstructured":"Silvestris N, Galeta D, Colucci G (2009) Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi sarcoma. Anticancer Res 29:675\u2013676","journal-title":"Anticancer Res"},{"key":"568_CR21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/cncr.21791","volume":"106","author":"L. Fardet","year":"2006","unstructured":"Fardet L, Stoebner PE, Bachelez H et al (2006) Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer 106: 1785\u20131789","journal-title":"Cancer"},{"key":"568_CR22","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.2165\/00063030-200923020-00001","volume":"23","author":"R.J. Sullivan","year":"2009","unstructured":"Sullivan RJ, Pantanowitz L, Dezube BJ (2009) Targeted therapy for Kaposi sarcoma. BioDrugs 23:6975","journal-title":"BioDrugs"},{"key":"568_CR23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0360-3016(90)90482-Y","volume":"19","author":"A.M. Berson","year":"1990","unstructured":"Berson AM, Quivey JM, Harris JW, Wara WM (1990) Radiation therapy for AIDS-related Kaposi sarcoma. Int J Radiat Oncol Biol Phys 19:569\u2013575","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"568_CR24","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1016\/j.febslet.2007.11.069","volume":"581","author":"S. Basciani","year":"2007","unstructured":"Basciani S, Vona R, Matarrese P et al (2007) Imatinib interferes with survival of multidrug resistant Kaposi sarcoma cells. FEBS Lett 581:5897\u20135903","journal-title":"FEBS Lett"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0568-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-010-0568-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-010-0568-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:50:50Z","timestamp":1559447450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-010-0568-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s12094-010-0568-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}